Financial Year 2025/26 | Version: MED-CG-006-4 | Signed: March 2026
Introduction from the CEO
MCL Medics is committed to respecting human rights in all aspects of its business. We take seriously our obligations under the Modern Slavery Act 2015 and recognise that tackling modern slavery requires continuous vigilance in our own operations, in our recruitment practices, and throughout our supply chains.
We foster a culture where every individual is treated with dignity and respect. Anyone with concerns about unethical behaviour in any part of our business is encouraged to raise them without fear of retaliation, through our confidential whistleblowing process.
This statement sets out the steps MCL Medics has taken during the financial year 2025/26 to ensure that slavery and human trafficking are not taking place in any part of our organisation or supply chains. It is made in accordance with Section 54(1) of the Modern Slavery Act 2015 and will be reviewed annually.
1. About MCL Medics
This statement applies to The MCL Group (Int) Ltd, trading as MCL Medics (referred to throughout as “MCL Medics” or “the Company”).
MCL Medics provides efficient and professional services to clients across a wide range of sectors, both public and private, nationally and internationally. We deliver tailor-made solutions for the operational challenges faced by organisations, while providing rewarding employment to our directly employed and contract staff.
2. Defining Modern Slavery
MCL Medics recognises that modern slavery is a serious crime and a violation of fundamental human rights. For the purposes of this statement, modern slavery encompasses:
- Human trafficking: the recruitment, movement, or receipt of individuals through force, fraud, or deception for the purpose of exploitation
- Forced labour: compelling a person to work through mental or physical threat, coercion, or the confiscation of identity documents
- Bonded labour: where a person is controlled by an employer through debt, abuse, or threat of abuse
- Dehumanisation: treating a person as a commodity or item of property to be bought or sold
- Restriction of movement: physically constraining individuals or otherwise limiting their freedom of movement
- Child labour: the employment of children in a manner that is harmful, hazardous, or contrary to their best interests
3. Our Supply Chains
As a professional services organisation, MCL Medics does not manufacture physical products. Our supply chains are primarily focused on the provision of services to clients and are therefore relatively contained compared to manufacturing or retail sectors.
MCL Medics operates principally as a first-tier supplier and has limited contractual relationships with lower-tier suppliers. Our key supply chain categories include:
- Staffing and workforce solutions
- Technology and IT services
- Office supplies and facilities management
- Professional and compliance services
We maintain a register of our key suppliers and conduct periodic reviews of those relationships to assess compliance with our ethical standards.
4. Risk Assessment
MCL Medics has assessed its exposure to modern slavery risk across its operations and supply chains. As a UK-based professional services provider with a predominantly domestic supply chain, we consider our overall risk profile to be relatively low. However, we recognise that no organisation is entirely without risk, and we take a proactive approach to identifying and mitigating potential exposure.
Areas identified as carrying a higher relative risk include:
- Use of temporary, contract, or agency workers where oversight may be more limited
- Procurement of services from sectors or geographies with weaker labour protections
- Sub-contracting arrangements where visibility of working conditions may be reduced
We review this risk assessment annually and update our controls accordingly.
5. Due Diligence and Steps Taken
In accordance with Section 54(4) of the Modern Slavery Act 2015, MCL Medics has taken the following steps during the reporting period to prevent modern slavery in its operations and supply chains:
Governance and Leadership
- Senior management formally acknowledge their responsibility to address modern slavery and labour exploitation in MCL Medics’ own operations and supply chains
- The Risk & Compliance Team holds primary responsibility for monitoring and enforcing compliance with this statement
Recruitment and Employment
- All recruitment processes include robust Right to Work checks in compliance with UK immigration legislation
- Payroll processes include systematic checks to identify multiple salary payments to the same bank account, which may indicate forced labour or financial control
- MCL Medics does not charge recruitment fees to workers and does not retain original identity documents
Supply Chain Controls
- Supplier contracts include termination clauses in the event a supplier is found, or is reasonably suspected, to be involved in modern slavery
- Procurement processes include anti-slavery checks and due diligence on new and existing suppliers
- Annual reviews of our existing supply chain are conducted to evaluate supplier compliance with our ethical standards
Reporting and Transparency
- A confidential whistleblowing process is in place, providing guidance on how to report suspected instances of modern slavery safely and without fear of retaliation
- MCL Medics has not, to its knowledge, conducted business with any organisation found to have been involved in modern slavery during this reporting period
6. Training and Awareness
MCL Medics recognises that informed and vigilant employees are essential to preventing modern slavery. All new employees are required to complete modern slavery awareness training as part of their induction programme.
Training covers the definition of modern slavery, how to recognise warning signs in the workplace and supply chain, and the process for raising concerns. Refresher training is provided periodically to ensure awareness remains current.
7. Key Performance Indicators
MCL Medics measures the effectiveness of its approach to combating modern slavery through the following key performance indicators:
- Percentage of new staff completing modern slavery training at induction (target: 100%)
- Annual completion of supply chain review and supplier evaluation
- Completion of periodic recruitment process audits
- Number of whistleblowing disclosures received and outcomes recorded
- Number of supplier contracts reviewed or updated to include anti-slavery clauses
8. Supporting Policies
This statement is supported by the following MCL Medics policies, which further define our approach to ethical business conduct:
- Corporate Social Responsibility Policy
- Supplier Code of Conduct
- Recruitment Policy
- Whistleblowing Policy
These policies are reviewed regularly and updated to reflect changes in legislation and best practice.
9. Remediation
In the event that modern slavery is identified within MCL Medics or its supply chains, the Company is committed to taking swift and effective action. This includes:
- Immediately reporting suspected cases to the relevant authorities, including the National Crime Agency and the Modern Slavery Helpline (0800 0121 700)
- Suspending or terminating commercial relationships with suppliers found to be involved in modern slavery, pending investigation
- Cooperating fully with law enforcement and regulatory bodies
- Offering appropriate support to any individuals identified as potential victims of modern slavery
10. Slavery Compliance Officer
All concerns, disclosures, or queries relating to modern slavery within MCL Medics or its supply chains should be directed to the Risk & Compliance Team. The Team will assess each matter and take appropriate action in accordance with MCL Medics’ obligations under the Modern Slavery Act 2015.
Concerns may also be reported anonymously via our whistleblowing channel.
Statement Sign-Off
This statement is made in pursuance of Section 54(1) of the Modern Slavery Act 2015 and covers the financial year 2025/26. It will be reviewed and updated for each subsequent financial year.
Richard O’Donnell
Chief Executive Officer, MCL Medics
March 2026